Editing Cabergoline (section)

===Pregnancy and lactation===
Relatively little is known about the effects of this medication during pregnancy and lactation. In some cases the related [[bromocriptine]] may be an alternative when pregnancy is expected.{{Citation needed|date=August 2011}}

* [[Pregnancy]]: available preliminary data indicates a somewhat increased rate of [[congenital]] abnormalities in patients who became pregnant while treated with cabergoline.{{Citation needed|reason=due to use as adjunct therapy with IVF, citation needed to clarify type of abnormalities, whether increase is meaningful, when treatment occurred, etc.|date=August 2011}}.  However, one study concluded that "foetal exposure to cabergoline through early pregnancy does not induce any increase in the risk of miscarriage or foetal malformation."<ref>{{cite journal | vauthors = Colao A, Abs R, Bárcena DG, Chanson P, Paulus W, Kleinberg DL | title = Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study | journal = Clinical Endocrinology | volume = 68 | issue = 1 | pages = 66–71 | date = January 2008 | pmid = 17760883 | doi = 10.1111/j.1365-2265.2007.03000.x | s2cid = 38408935 }}</ref> 
* [[Lactation]]: In rats cabergoline was found in the maternal [[milk]]. Since it is not known if this effect also occurs in humans, breastfeeding is usually not recommended if/when treatment with cabergoline is necessary.
* [[Lactation suppression]]: In some countries cabergoline (Dostinex) is sometimes used as a lactation suppressant. It is also used in veterinary medicine to treat [[false pregnancy]] in dogs.